Abstract
Because treatment for breast cancer may adversely affect skeletal metabolism, we investigated vertebral fracture risk in women with non-metastatic breast cancer. The prevalence of vertebral fracture was similar in women at the time of first diagnosis to that in an age-matched sample of the general population. The incidence of vertebral fracture, however, was nearly five times greater than normal in women from the time of first diagnosis [odds ratio (OR), 4.7; 95% confidence interval (95% CI), 2.3–9.9], and 20-fold higher in women with soft-tissue metastases without evidence of skeletal metastases (OR, 22.7; 95% CI, 9.1–57.1). We conclude that vertebral fracture risk is markedly increased in women with breast cancer. © 1999 Cancer Research Campaign
Keywords: vertebral fracture, breast cancer, skeletal metastases
Full Text
The Full Text of this article is available as a PDF (59.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Filipponi P., Cristallini S., Rizzello E., Policani G., Fedeli L., Gregorio F., Boldrini S., Troiani S., Massoni C. Cyclical intravenous clodronate in postmenopausal osteoporosis: results of a long-term clinical trial. Bone. 1996 Feb;18(2):179–184. doi: 10.1016/8756-3282(95)00442-4. [DOI] [PubMed] [Google Scholar]
- Hayward J. L., Meakin J. W., Stewart H. J. Assessment of response and recurrence in breast cancer. Semin Oncol. 1978 Dec;5(4):445–449. [PubMed] [Google Scholar]
- Kanis J. A., Powles T., Paterson A. H., McCloskey E. V., Ashley S. Clodronate decreases the frequency of skeletal metastases in women with breast cancer. Bone. 1996 Dec;19(6):663–667. doi: 10.1016/s8756-3282(96)00285-2. [DOI] [PubMed] [Google Scholar]
- Powell G. J., Southby J., Danks J. A., Stillwell R. G., Hayman J. A., Henderson M. A., Bennett R. C., Martin T. J. Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res. 1991 Jun 1;51(11):3059–3061. [PubMed] [Google Scholar]
- Saarto T., Blomqvist C., Välimäki M., Mäkelä P., Sarna S., Elomaa I. Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients. J Clin Oncol. 1997 Apr;15(4):1341–1347. doi: 10.1200/JCO.1997.15.4.1341. [DOI] [PubMed] [Google Scholar]
- Spector T. D., McCloskey E. V., Doyle D. V., Kanis J. A. Prevalence of vertebral fracture in women and the relationship with bone density and symptoms: the Chingford Study. J Bone Miner Res. 1993 Jul;8(7):817–822. doi: 10.1002/jbmr.5650080707. [DOI] [PubMed] [Google Scholar]
- Taube T., Elomaa I., Blomqvist C., Beneton M. N., Kanis J. A. Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer. Bone. 1994 Mar-Apr;15(2):161–166. doi: 10.1016/8756-3282(94)90703-x. [DOI] [PubMed] [Google Scholar]
- Utz J. P., Melton L. J., 3rd, Kan S. H., Riggs B. L. Risk of osteoporotic fractures in women with breast cancer: a population-based cohort study. J Chronic Dis. 1987;40(2):105–113. doi: 10.1016/0021-9681(87)90061-0. [DOI] [PubMed] [Google Scholar]